Search
for
Sort by
Research 271–300 of 610
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Polycystic ovary syndrome and psychological distress: Urban–rural comparison among reproductive-aged women in Bangladesh
- Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
- Cardiometabolic profile of young women with hypoprolactinemia
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- Cardiometabolic comorbidities associated with androgenetic alopecia: Findings from a sex-stratified, propensity-matched national cohort
- Association between hair loss and cardiometabolic diseases in Chinese adults: a cross-sectional analysis in Tianning Cohort
- Repurposing of Drugs for Cardiometabolic Disorders: An Out and Out Cumulation
- PCOS and Cardiometabolic Health over the Reproductive Years
- A Multidisciplinary Lifestyle Intervention for Women with Polycystic Ovary Syndrome: The Role of a Pulse-Based Diet and Aerobic Exercise on Reproductive, Cardio-Metabolic, and Quality of Life Outcomes
- Cardiometabolic aspects of the polycystic ovary syndrome
- Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome
- Impaired Cardiometabolic Effects of Bromocriptine in Men With Early‐Onset Androgenic Alopecia
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Hair Manganese as a Marker of Cardiometabolic Status Rather than Coronary Artery Disease Severity—An Exploratory Pilot Study
- Facial Appearance and Markers of Cardiometabolic Risk in Healthy Adult Men
- Nutrition and Emotional Health Education: The Use of Emotional Intelligence and a Plant-Based Diet to Reduce Cardiometabolic Risk
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Targets to treat androgen excess in polycystic ovary syndrome
- Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
- Lipin 1 Gene Polymorphisms in Polycystic Ovary Syndrome
- Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
- From PCOS to PMOS: The Impact of Physical Activity, Diet, and Metabolic Health on the Course of Polyendocrine Metabolic Ovarian Syndrome
- Knowledge gaps and health practices related to polycystic ovary syndrome among women in Southwestern Saudi Arabia: a cross-sectional study
- POLYCYSTIC OVARY SYNDROME: DIAGNOSTIC CRITERIA AND TREATMENT METHODS